Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA

Benedetto Vitiello, Joanne B. Severe, Laurence L. Greenhill, L. Eugene Arnold, Howard B. Abikoff, Oscar G. Bukstein, Glen R. Elliott, Lily Hechtman, Peter S. Jensen, Stephen P. Hinshaw, John S. March, Jeffrey H. Newcorn, James M. Swanson, Dennis P. Cantwell

Research output: Contribution to journalArticle

114 Scopus citations

Abstract

Objectives: To examine the trajectory of methylphenidate (MPH) dosage over time, following a controlled titration, and to ascertain how accurately the titration was able to predict effective long-term treatment in children with attention-deficit/hyperactivity disorder (ADHD). Method: Using the 14-month-treatment database of the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA), the outcome of the initial placebo-controlled, double-blind, randomized daily switch titration of MPH was compared with the subsequent maintenance pharmacotherapy. Children received monthly monitoring visits and, when needed, medication adjustments. Results: Of the 198 children for whom MPH was the optimal treatment at titration (mean ± SD dose: 30.5 ± 14.2 mg/day), 88% were still taking MPH at the end of maintenance (mean dose 34.4 ± 13.3 mg/day), Titration-determined dose and end-of-maintenance dose were significantly correlated (r = 0.52-0.68). Children receiving combined pharmacotherapy and behavioral treatment ended maintenance on a lower dose (31.1 ± 11.7 mg/day) than did children receiving pharmacotherapy only (38,1 ± 14.2 mg/day). Of the 230 children for whom titration identified an optimal treatment, 17% continued both the assigned medication and dosage throughout maintenance. The mean number of pharmacological changes per child was 2.8 ± 1.8 (SD), and time to first change was 4.7 months ± 0.3 (SE). Conclusions: For most children, initial titration found a dose of MPH in the general range of the effective maintenance dose, but did not prevent the need for subsequent maintenance adjustments. For optimal pharmacological treatment of ADHD, both careful initial titration and ongoing medication management are needed.

Original languageEnglish (US)
Pages (from-to)188-196
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume40
Issue number2
DOIs
StatePublished - Jan 1 2001

Keywords

  • Attention deficit
  • Attention-deficit/hyperactivity disorder
  • Hyperactivity
  • Methylphenidate

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA'. Together they form a unique fingerprint.

  • Cite this

    Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., Elliott, G. R., Hechtman, L., Jensen, P. S., Hinshaw, S. P., March, J. S., Newcorn, J. H., Swanson, J. M., & Cantwell, D. P. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 188-196. https://doi.org/10.1097/00004583-200102000-00013